3rd Quarter - Amendment

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Firm
Client
Income
—
Expenses
$425,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 17, 2024 $540,000 Replaced
3rd Quarter - Amendment (this page) Nov 8, 2024 $425,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; FY 2024 budget and appropriations processes, artificial intelligence in laboratory services; public-private sector testing response in general and specific to Influenza A (H5) avian flu, monkeypox and oropouche; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, American Privacy Rights Act of 2024; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act; and H.R. 2369, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS New —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Natl Security Council (NSC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8702 (118th), H.R. 8818 (118th), S. 4532 (118th), S. 1000 (118th), H.R. 2377 (118th), H.R. 2369 (118th)

Medicare/Medicaid MMM

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act; H.R. 2407, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS New —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 8702 (118th), H.R. 2377 (118th), H.R. 2407 (118th), S. 4532 (118th), S. 1000 (118th), H.R. 1691 (118th)

Health Issues HCR

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; price transparency for clinical laboratory services; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, American Privacy Rights Act of 2024; Improving Seniors Timely Access to Care Act; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023; S. 3548, Health Care PRICE Transparency Act.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS New —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 1000 (118th), H.R. 8818 (118th), S. 3548 (118th), H.R. 2377 (118th), H.R. 2369 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.